Online Program Home
  My Program

All Times EDT

Legend:
* = applied session       ! = JSM meeting theme

Activity Details

341 Wed, 8/5/2020, 10:00 AM - 2:00 PM Virtual
Topics in Adaptive Designs: Sample Size, Randomization and Related Topics — Contributed Papers
Biopharmaceutical Section
Chair(s): Christine Gause, Merck & Co, Inc
Sample Size Recalculation Methods for Three-Arm Non-Inferiority Trials
Lanyu Lei, Pfizer Inc.
Deep Neural Networks Guided Hypothesis Testing Framework with Application to Sample Size Reassessment Adaptive Clinical Trials
Tianyu Zhan, AbbVie; Jian Kang, University of Michigan
Bayesian Adaptive Randomization for A Phase 2 Dose-Ranging Clinical Trial
Morgan de Ferrante, Regeneron Pharmaceuticals, Inc. ; Ming-Dauh Wang, Regeneron Pharmaceuticals, Inc.
New Covariate-Adaptive Randomization Procedure: Balancing Continuous and Discrete Covariates Simultaneously
Yifan Zhou; feifang Hu, George Washington University
Statistical Considerations of Data Transformation in Non-Inferiority Testing
Ran Bi, FDA/HHS; Yi Tsong, FDA/HHS
Robust Blocked Response-Adaptive Randomization Designs
Thevaa Chandereng, University of Wisconsin; Rick Chappell, University of Wisconsin
Integrated Multiple Adaptive Clinical Trial Design Involving Sample Size Re-Estimation and Response-Adaptive Randomization for Continuous and Binary Outcomes
Christine M Orndahl, Virginia Commonwealth University Dept of Biostatistics
Adaptive Bayesian Clinical Trial Design for Improving Robustness to Sample Size Calculation Assumptions: A Simulation Study
Shirley Liao, Biogen; Fabio Pellegrini, Biogen International GmbH; Bernd Kieseier, Biogen; Christophe Hotermans, Biogen; Jason Mendoza, Biogen; Christine Lebrun, Centre Hospitalier Universitaire de Nice; Daniel Pelletier, University of Southern California; Aksel Siva, e Department of Neurology of Istanbul University, Cerrahpa?a School of Medicine; Maria Pia Sormani, Università degli Studi di Genova; Orhun Kantarci, Mayo Clinic ; Darin Okuda, UT Southwestern Medical Center; Carl de Moor, Biogen Inc